Next Article in Journal
Phase 3 Randomized, Multicenter, Placebo-Controlled Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of an Adjuvanted Cell Culture-Derived, H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects
Previous Article in Journal
COVID-19 Parental Vaccine Hesitancy in Romania: Nationwide Cross-Sectional Study
 
 
Article

Article Versions Notes

Vaccines 2022, 10(4), 495; https://doi.org/10.3390/vaccines10040495
Action Date Notes Link
article xml file uploaded 23 March 2022 11:01 CET Original file -
article xml uploaded. 23 March 2022 11:01 CET Update https://www.mdpi.com/2076-393X/10/4/495/xml
article pdf uploaded. 23 March 2022 11:01 CET Version of Record https://www.mdpi.com/2076-393X/10/4/495/pdf
article html file updated 23 March 2022 11:02 CET Original file -
article html file updated 1 August 2022 07:08 CEST Update https://www.mdpi.com/2076-393X/10/4/495/html
Back to TopTop